Exclusive: AI-Generated DNA Startup Raises $50M Seed Round
A team of researchers behind AI-driven biology raises a $50 million seed round to scale models that read, write, and ...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesA team of researchers behind AI-driven biology raises a $50 million seed round to scale models that read, write, and ...
Steven Spielberg's Disclosure Day opens to a robust domestic debut and a broad global haul, anchoring a broader conve...
When headlines scream about a space setback, investors shift their bets. This article breaks down how Blue Origin’s r...
SpaceX's IPO debut has turned into a high-velocity, meme-like run as investors chase a limited float. Crypto-linked f...
Two giant asset managers closed a record private credit financing to accelerate Anthropic's compute. Here’s what that...
Retail buyers piled into SpaceX shares over a two-day window, creating a record pace that outstripped every other U.S...
A new era at the Fed could be starting, sparked by a bold move from a hypothetical chair. This piece breaks down what...
Tech-led gains paced a Nasdaq climb as investors reassessed hawkish Fed signals. The index rose, while traders weighe...
CME Group has sued the CFTC over how perpetual futures are classified, triggering a formal cftc, request public comme...
Public figures face a financial balancing act around exclusive conferences. This piece uses sophia bush defends dialo...
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
SpaceX stumbled after its blockbuster IPO, with shares drifting lower as investors weigh high growth bets in Starlink...